These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27278063)

  • 21. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group.
    Kessler KR; Skutta M; Benecke R
    J Neurol; 1999 Apr; 246(4):265-74. PubMed ID: 10367694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin injection for the treatment of oromandibular dystonia.
    Blitzer A; Brin MF; Greene PE; Fahn S
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):93-7. PubMed ID: 2916831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-Aided Design/Computer-Assisted Manufacture-Derived Needle Guide for Injection of Botulinum Toxin into the Lateral Pterygoid Muscle in Patients with Oromandibular Dystonia.
    Yoshida K
    J Oral Facial Pain Headache; 2018 Spring; 32(2):e13-e21. PubMed ID: 29694466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oromandibular Dystonia Causing Recurrent Mandibular Open Lock in Two Adolescents Managed with Botulinum Toxin.
    Perez CV; Okeson J
    J Dent Child (Chic); 2019 Jan; 86(1):47-52. PubMed ID: 30992101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    Samotus O; Lee J; Jog M
    PLoS One; 2017; 12(6):e0178670. PubMed ID: 28586370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study.
    Teuschl Y; Bancher C; Brainin M; Dachenhausen A; Matz K; Pinter MM
    J Neural Transm (Vienna); 2022 Jan; 129(1):49-53. PubMed ID: 34689260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smothering dystonia in a patient with oromandibular dystonia.
    Grill S
    Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.
    Esper CD; Freeman A; Factor SA
    Parkinsonism Relat Disord; 2010 Aug; 16(7):438-41. PubMed ID: 20494607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The application of botulinum toxin in oromandibular, pharyngeal and laryngeal dystonia].
    Olthoff A; Laskawi R
    HNO; 2012 Jun; 60(6):475-8. PubMed ID: 22669434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia.
    Ansved T; Odergren T; Borg K
    Neurology; 1997 May; 48(5):1440-2. PubMed ID: 9153487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
    Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.